The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.
Open Access Government takes a look at the ways in which Olivier Véran, the French Minister for Health and Solidarity, has supported French citizens through a health crisis and beyond.
Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.
Timothy Kwok, Professor at The Chinese University of Hong Kong, tells us about the Electronic Cognitive Screen (EC-Screen) that gives a brief and user-friendly digital cognitive test for the detection of dementia in older people.
Mental Health Europe point out that the New Pact on Migration and Asylum leaves behind migrants with disabilities and mental health problems, suggesting how this oversight could be resolved.
SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.
The rise of the virtual ward is charted here by Max Mckiernan, L2S2’s Marketing Manager and Jane Aldridge, Co-Founder/CBDO/CFO, including analysis of why COVID may save the NHS.
Here, we discover that SymlConnect digitises the paper-processes, offering remote monitoring to improve efficiency in care monitoring and reducing the waiting list exacerbated by the COVID-19 pandemic.
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
Marco Landi, President of Council of European Dentists, considers dentistry during the COVID-19 pandemic and the extent to which oral health is still a priority.
The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.
